Taiwan - Delayed Quote TWD

SCI Pharmtech, Inc. (4119.TW)

70.70
-1.60
(-2.21%)
As of 10:24:36 AM GMT+8. Market Open.
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,523,738
1,523,738
1,204,159
899,738
864,217
Cost of Revenue
1,113,073
1,113,073
853,836
608,559
656,128
Gross Profit
410,665
410,665
350,323
291,179
208,089
Operating Expense
212,380
212,380
190,023
172,209
134,431
Operating Income
198,285
198,285
160,300
118,970
73,658
Net Non Operating Interest Income Expense
2,489
2,489
-2,843
-74
559
Pretax Income
646,857
646,857
364,190
387,820
65,506
Tax Provision
112,179
112,179
69,469
79,040
9,810
Net Income Common Stockholders
534,678
534,678
294,721
308,780
55,696
Diluted NI Available to Com Stockholders
534,678
534,678
294,721
308,780
55,696
Basic EPS
4.47
--
2.70
2.88
0.51
Diluted EPS
4.46
--
2.69
2.87
0.51
Basic Average Shares
119,614.77
--
109,155.93
107,305
108,997.62
Diluted Average Shares
119,882.96
--
109,561.71
107,593
109,206.74
Total Expenses
1,325,453
1,325,453
1,043,859
780,768
790,559
Net Income from Continuing & Discontinued Operation
534,678
534,678
294,721
308,780
55,696
Normalized Income
531,689.09
531,689.09
296,708.52
321,046.96
53,789.76
Interest Income
8,029
8,029
3,447
998
600
Interest Expense
5,540
5,540
6,290
1,072
41
Net Interest Income
2,489
2,489
-2,843
-74
559
EBIT
652,397
652,397
370,480
388,892
65,547
EBITDA
886,189
886,189
515,774
479,504
129,255
Reconciled Cost of Revenue
1,113,073
1,113,073
853,836
608,559
656,128
Reconciled Depreciation
233,792
233,792
145,294
90,612
63,708
Net Income from Continuing Operation Net Minority Interest
534,678
534,678
294,721
308,780
55,696
Total Unusual Items Excluding Goodwill
3,616
3,616
-2,456
-15,407
2,242
Total Unusual Items
3,616
3,616
-2,456
-15,407
2,242
Normalized EBITDA
882,573
882,573
518,230
494,911
127,013
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
627.09
627.09
-468.48
-3,140.04
335.76
12/31/2021 - 1/7/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1720.TW Standard Chemical & Pharmaceutical Co. Ltd.
59.00
-1.01%
 
4108.TW PhytoHealth Corporation
15.10
-1.31%
 
4746.TW Formosa Laboratories, Inc.
64.30
+0.94%
 
4105.TWO TTY Biopharm Company Limited
75.90
-0.39%
 
1789.TW ScinoPharm Taiwan, Ltd.
19.20
+0.79%
 
1707.TW Grape King Bio Ltd
137.50
-0.72%
 
1731.TW Maywufa Company Ltd.
23.00
+0.44%
 
3705.TW YungShin Global Holding Corporation
62.20
-8.80%
 
1795.TW Lotus Pharmaceutical Co., Ltd.
237.00
+3.50%
 
4114.TWO Synmosa Biopharma Corporation
32.75
+0.15%